Post-Transplant Lymphoproliferative Disease
specific7
Centers
0
Active Trials
$14M
Cancer Funding
Top Centers for Post-Transplant Lymphoproliferative Disease(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive High-Volume Research Center | 72.1 |
| 2 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 67.1 |
| 3 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 62.1 |
| 4 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 57.1 |
| 5 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 52.1 |
| 6 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 44.6 |
| 7 | NCI Clinical | 44.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →